$-0.77 EPS Expected for Tetraphase Pharmaceuticals (TTPH); Chipotle Mexican Grill (CMG) Sentiment Is 0.64

July 21, 2017 - By Darrin Black

Analysts expect Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) to report $-0.77 EPS on August, 3.They anticipate $0.30 EPS change or 63.83% from last quarter’s $-0.47 EPS. After having $-0.79 EPS previously, Tetraphase Pharmaceuticals Inc’s analysts see -2.53% EPS growth. About 622,187 shares traded or 46.50% up from the average. Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) has risen 106.58% since July 21, 2016 and is uptrending. It has outperformed by 89.88% the S&P500.

Chipotle Mexican Grill, Inc. , together with its subsidiaries, operates Chipotle Mexican Grill restaurants. The company has market cap of $9.45 billion. The Company’s Chipotle Mexican Grill restaurants serve a menu of burritos, tacos, burrito bowls (a burrito without the tortilla) and salads. It has a 105.04 P/E ratio. As of December 31, 2016, the Company managed its activities and restaurants based on 11 regions.

Since January 1, 0001, it had 1 insider buy, and 0 sales for $159,084 activity.

Pershing Square Capital Management L.P. holds 18.39% of its portfolio in Chipotle Mexican Grill, Inc. for 2.88 million shares. Tybourne Capital Management Hk Ltd owns 690,891 shares or 12.65% of their US portfolio. Moreover, Aeris Capital Holding Gmbh has 6.8% invested in the company for 55,061 shares. The California-based Mig Capital Llc has invested 6.5% in the stock. Marianas Fund Management Llc, a New York-based fund reported 67,800 shares.

Analysts await Chipotle Mexican Grill, Inc. (NYSE:CMG) to report earnings on July, 25 after the close. They expect $2.19 EPS, up 151.72% or $1.32 from last year’s $0.87 per share. CMG’s profit will be $59.92M for 39.43 P/E if the $2.19 EPS becomes a reality. After $1.60 actual EPS reported by Chipotle Mexican Grill, Inc. for the previous quarter, Wall Street now forecasts 36.88% EPS growth.

Ratings analysis reveals 18% of Chipotle Mexican Grill’s analysts are positive. Out of 11 Wall Street analysts rating Chipotle Mexican Grill, 2 give it “Buy”, 4 “Sell” rating, while 5 recommend “Hold”. The lowest target is $280.0 while the high is $483.0. The stock’s average target of $388.57 is 12.50% above today’s ($345.41) share price. CMG was included in 11 notes of analysts from September 8, 2016. The firm earned “Sell” rating on Wednesday, October 12 by Maxim Group. Piper Jaffray maintained the stock with “Overweight” rating in Thursday, September 8 report. Guggenheim downgraded Chipotle Mexican Grill, Inc. (NYSE:CMG) on Thursday, November 17 to “Sell” rating. The firm has “Neutral” rating by Wedbush given on Thursday, January 5. The stock of Chipotle Mexican Grill, Inc. (NYSE:CMG) has “Outperform” rating given on Tuesday, October 18 by RBC Capital Markets. Nomura maintained it with “Neutral” rating and $372.0 target in Monday, October 17 report. The stock has “Neutral” rating by JP Morgan on Tuesday, January 17. On Wednesday, October 26 the stock rating was maintained by Deutsche Bank with “Sell”. Credit Suisse downgraded the shares of CMG in report on Wednesday, October 26 to “Neutral” rating. On Wednesday, September 21 the stock rating was maintained by Goldman Sachs with “Neutral”.

About 2.38 million shares traded or 70.00% up from the average. Chipotle Mexican Grill, Inc. (CMG) has risen 7.62% since July 21, 2016 and is uptrending. It has underperformed by 9.08% the S&P500.

Among 12 analysts covering Tetraphase Pharmaceuticals (NASDAQ:TTPH), 3 have Buy rating, 0 Sell and 9 Hold. Therefore 25% are positive. Tetraphase Pharmaceuticals had 18 analyst reports since August 6, 2015 according to SRatingsIntel. The stock has “Buy” rating by SunTrust on Thursday, November 19. The firm has “Hold” rating by Brean Capital given on Wednesday, September 9. The stock of Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) earned “Market Perform” rating by BMO Capital Markets on Tuesday, April 12. The rating was maintained by Stifel Nicolaus on Thursday, August 6 with “Buy”. The firm earned “Hold” rating on Wednesday, September 9 by Needham. The firm has “Neutral” rating given on Wednesday, September 9 by SunTrust. Gabelli downgraded Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) on Friday, May 13 to “Neutral” rating. The firm has “Market Perform” rating by JMP Securities given on Wednesday, September 9. The firm earned “Hold” rating on Wednesday, September 9 by Cantor Fitzgerald. Robert W. Baird downgraded Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) rating on Wednesday, September 9. Robert W. Baird has “Neutral” rating and $10 target.

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $348.84 million. The Firm uses its chemistry technology to create antibiotics for multidrug-resistant infections. It currently has negative earnings. The Firm is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant gram-negative infections.

Investors sentiment increased to 1.29 in Q4 2016. Its up 0.17, from 1.12 in 2016Q3. It improved, as 12 investors sold Tetraphase Pharmaceuticals Inc shares while 22 reduced holdings. 12 funds opened positions while 32 raised stakes. 17.45 million shares or 11.89% less from 19.80 million shares in 2016Q3 were reported. Legal And General Grp Public Limited Co invested in 12,301 shares. Amer Intll Gru owns 20,904 shares or 0% of their US portfolio. Renaissance Llc holds 354,713 shares or 0% of its portfolio. Northern Trust reported 0% stake. Massachusetts-based Numeric Lc has invested 0.01% in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). Dow Chemical De stated it has 65,000 shares. Rhenman & Partners Asset Mgmt has invested 0.23% of its portfolio in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). The Pennsylvania-based Pnc Fincl Svcs Grp has invested 0% in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). Blackrock Limited Liability Corporation invested 0% in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH). Jpmorgan Chase And Company invested in 0% or 12,281 shares. 157,429 are held by Millennium Management Ltd Llc. Wells Fargo Communications Mn reported 141,966 shares or 0% of all its holdings. Natl Bank Of Mellon holds 0% or 181,783 shares. Fmr Ltd holds 0% of its portfolio in Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) for 1.97M shares. Barclays Plc accumulated 0% or 33,688 shares.